Clinical Trial Update: Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED) [Phase 4]

View source ↗

Summary

A completed Phase 4 analysis examined peripheral blood mononuclear cells from patients with Ankylosing Spondylitis during infliximab treatment, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Spondylitis, Ankylosing | Phase 4 | Status: COMPLETED | Results posted: 2010-04-09